More than 5 million Medicare beneficiaries struggle to afford prescription medications. Among adults 65 and older, Black and Latino beneficiaries are most likely to experience affordability problems. Medicare beneficiaries with lower incomes and those under age 65 also had above-average rates of not taking needed medications due to cost.
ASPE Data Point
Reports
Displaying 31 - 40 of 43. 10 per page. Page 4.
Advanced SearchASPE Data Point
Assessing Uninsured Rates in Early Care and Education Workers
This Data Point presents current estimates of uninsured rates among early care and education workers (ECE), which includes individuals employed by Head Start, childcare center providers, and preschools. These populations have lower incomes on average and often lack access to benefits, including health coverage, commonly received by teachers in the K-12 system and post-secondary schools.
ASPE Data Point
Infographic: A Framework for Father Engagement in Services
This infographic visualizes a framework for father engagement in human services, detailing key approaches and strategies used by programs, organizations, and systems.
Related Products:
ASPE Data Point
Infographic: What is Father Engagement?
This infographic defines "father engagement" and highlights ways programs, organizations, and systems play a role in promoting father engagement in services.
Related Products:
ASPE Data Point
Estimates of Medicaid Eligibility in Non-Expansion States
This Data Point presents estimates of potential Medicaid eligibility among uninsured, non-elderly adults in states that have not expanded Medicaid coverage to adults with incomes up to 138% of the Federal Poverty Level (FPL).
ASPE Data Point
Current Estimates of Supply and Utilization of Immune Globulin Products
In February 2007, the Eastern Research Group (ERG) submitted to the Office of the Assistant Secretary for Planning and Evaluation (ASPE) Analysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IG
ASPE Data Point
Data point: Prescription Pharmaceutical Price Changes since the Release of the President’s Drug Pricing Blueprint
Using manufacturer-reported prescription pharmaceutical prices, we observe that the number of price increases has been reduced considerably since the release of the President’s Drug Pricing Blueprint, compared to the same time period in the year prior.
ASPE Data Point
Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D
ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.
ASPE Data Point
Individual Market Premium Changes: 2013 – 2017
This ASPE Data Point analyzes premium increases from two data series, comparing premium costs in individual market plans purchased by consumers in 2013 to exchange plans purchased in 2017 in order to better determine how much premiums have increased since the ACA’s key provisions have taken effect.